dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniversidade Estadual de Campinas (UNICAMP)
dc.date.accessioned2018-12-11T17:17:34Z
dc.date.available2018-12-11T17:17:34Z
dc.date.created2018-12-11T17:17:34Z
dc.date.issued2018-01-02
dc.identifiermAbs, v. 10, n. 1, p. 46-54, 2018.
dc.identifier1942-0870
dc.identifier1942-0862
dc.identifierhttp://hdl.handle.net/11449/175803
dc.identifier10.1080/19420862.2017.1331804
dc.identifier2-s2.0-85041207291
dc.identifier2-s2.0-85041207291.pdf
dc.identifier8845835550637809
dc.identifier0000-0002-4292-3298
dc.description.abstractDespite fast advances in genomics and proteomics, monoclonal antibodies (mAbs) are still a valuable tool for areas such as the evolution of basic research in stem cells and cancer, for immunophenotyping cell populations, diagnosing and prognosis of diseases, and for immunotherapy. To summarize different subtractive immunization approaches successfully used for the production of highly specific antibodies, we identified scientific articles in NCBI PubMed using the following search terms: subtractive immunization, monoclonal antibody, tolerization, neonatal, high-zone tolerance, masking immunization. Patent records were also consulted. From the list of results, we included all available reports, from 1985 to present, that used any enhanced immunization technique to produce either polyclonal or monoclonal antibodies. Our examination yielded direct evidence that these enhanced immunization techniques are efficient in obtaining specific antibodies to rare epitopes, with different applications, such as to identify food contaminants or tumor cells.
dc.languageeng
dc.relationmAbs
dc.relation2,236
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectCyclophosphamide
dc.subjecthigh-zone tolerance
dc.subjectimmunogen
dc.subjectmonoclonal antibody
dc.subjectmultiple tolerization subtractive immunization
dc.subjectneonatal tolerization
dc.subjectsubtractive immunization
dc.subjecttolerogen
dc.titleEnhanced immunization techniques to obtain highly specific monoclonal antibodies
dc.typeOtros


Este ítem pertenece a la siguiente institución